Post-COVID syndrome in dialysis patients and kidney transplant recipients

M.  Kolesnyk; N.  Stepanova

doi:10.31450/ukrjnd.1(73).2022.10

M. Kolesnyk Державна установа «Інститут нефрології Національної Академії медичних наук України» https://orcid.org/0000-0001-6658-3729
N. Stepanova Державна установа «Інститут нефрології Національної Академії медичних наук України» https://orcid.org/0000-0002-1070-3602

DOI: https://doi.org/10.31450/ukrjnd.1(73).2022.10

Ключові слова: COVID-19, постковідний синдром, хронічна хвороба нирок VД стадії, реципієнти ниркового трансплантату, фактори ризику, наслідки, лікування

Анотація

Резюме. Пацієнти з хронічною хворобою нирок (ХХН) VД та реципієнти ниркового трансплантату, які перенесли коронавірусну хворобу 2019 (COVID-19), мають більш високий ризик розвитку постковідного синдрому (ПКС) порівняно з загальною популяцією. Однак детальної оцінки причин формування, особливостей перебігу та клінічних наслідків ПКС у цієї когорти пацієнтів поки немає. У цьому огляді ми аналізуємо опубліковані дослідження з проблеми ПКС у хворих на ХХН VД та РНТ для прогнозування розвитку ПКС, його лікування та профілактики.

Завантаження

Дані завантаження ще не доступні.

Посилання

Venkatesan P. NICE guideline on long COVID. Lancet Respir Med. 2021;9(2):129. doi: 10.1016/S2213-2600(21)00031-X.

Carfì A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603-605. doi: 10.1001/jama.2020.12603.

Cravedi P, Mothi SS, Azzi Y, Haverly M, Farouk SS, Pérez-Sáez MJ, et al. COVID-19 and kidney transplantation: Results from the TANGO International Transplant Consortium. Am J Transplant. 2020;20(11):3140-3148. doi: 10.1111/ajt.16185.

Valeri AM, Robbins-Juarez SY, Stevens JS, Ahn W, Rao MK, Radhakrishnan J, et al. Presentation and Outcomes of Patients with ESKD and COVID-19. J Am Soc Nephrol. 2020;31(7):1409-1415. doi: 10.1681/ASN.2020040470.

Yende S, Parikh CR. Long COVID and kidney disease. Nat Rev Nephrol. 2021;17(12):792-793. doi: 10.1038/s41581-021-00487-3.

Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. medRxiv [Preprint]. 2021;2021.01.27.21250617. doi: 10.1101/2021.01.27.21250617.

Barker-Davies RM, O'Sullivan O, Senaratne KPP, Baker P, Cranley M, Dharm-Datta S, et al. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med. 2020;54(16):949-959. doi: 10.1136/bjsports-2020-102596.

Varghese J, Sandmann S, Ochs K, Schrempf IM, Frömmel C, Dugas M, et al. Persistent symptoms and lab abnormalities in patients who recovered from COVID-19. Sci Rep. 2021;11(1):12775. doi: 10.1038/s41598-021-91270-8.

Mohiuddin Chowdhury ATM, Karim MR, Ali MA, Islam J, Li Y, He S. Clinical Characteristics and the Long-Term Post-recovery Manifestations of the COVID-19 Patients-A Prospective Multicenter Cross-Sectional Study. Front Med (Lausanne). 2021;8:663670. doi: 10.3389/fmed.2021.663670.

Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et al. Multiple Early Factors Anticipate Post-Acute COVID-19 Sequelae. Cell. 2022; doi: 10.1016/j.cell.2022.01.014.

Cervia C, Zurbuchen Y, Taeschler P, Ballouz T, Menges D, Hasler S, et al. Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat Commun. 2022;13(1):446. doi: 10.1038/s41467-021-27797-1.

Liu Q, Mak JWY, Su Q, Yeoh YK, Lui GC, Ng SSS, Zhang F, Li AYL, Lu W, Hui DS, Chan PK, Chan FKL, Ng SC. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022:gutjnl-2021-325989. doi: 10.1136/gutjnl-2021-325989.

Proal AD, VanElzakker MB. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front Microbiol. 2021;12:698169. doi: 10.3389/fmicb.2021.698169.

Banerjee D, Popoola J, Shah S, Ster IC, Quan V, Phanish M. COVID-19 infection in kidney transplant recipients. Kidney Int. 2020;97(6):1076-1082. doi: 10.1016/j.kint.2020.03.018.

Stepanova N, Driianska V, Korol L, Snisar L, Lebed L. Plasma oxalic acid and cardiovascular risk in end-stage renal disease patients: a prospective, observational cohort pilot study. Korean J Intern Med. 2022;37(1):167-178. doi: 10.3904/kjim.2020.561.

Mazur T, Demikhova N, Rudenko T, Yurchenko A, Yezhova O, Bokova S, et al. Chronic inflammation and progression of chronic kidney disease in patients with type 2 diabetes. Ukr J Nephrol Dial. 2021;4(72):36-43. doi: 10.31450/ukrjnd.4(72).2021.05.

Stepanova N. Role of Impaired Oxalate Homeostasis in Cardiovascular Disease in Patients With End-Stage Renal Disease: An Opinion Article. Front Pharmacol. 2021;12:692429. doi:10.3389/fphar.2021.692429.

Och A, Tylicki P, Polewska K, Puchalska-Reglińska E, Parczewska A et al. Persistent post-covid-19 syndrome in hemodialyzed patients—a longitudinal cohort study from the North of Poland. J Clin Med. 2021;10(19):4451. doi: 10.3390/jcm10194451.

Basic-Jukic N, Juric I, Furic-Cunko V, Katalinic L, Radic J, Bosnjak Z, et al. Follow-up of renal transplant recipients after acute COVID-19-A prospective cohort single-center study. Immun Inflamm Dis. 2021;9(4):1563-1572. doi: 10.1002/iid3.509.

Voorend CGN, van Oevelen M, Nieberg M, Meuleman Y, Franssen CFM, Joosten H, et al. Impact of the COVID-19 pandemic on symptoms of anxiety and depression and health-related quality of life in older patients with chronic kidney disease. BMC Geriatr. 2021;21(1):650. doi: 10.1186/s12877-021-02593-0.

Kremer D, Pieters TT, Verhaar MC, Berger SP, Bakker SJL, van Zuilen AD, et al. A systematic review and meta-analysis of COVID-19 in kidney transplant recipients: Lessons to be learned. Am J Transplant. 2021;21(12):3936-3945. doi: 10.1111/ajt.16742.

Bruchfeld A. The COVID-19 pandemic: consequences for nephrology. Nat Rev Nephrol. 2021;17(2):81-82. doi: 10.1038/s41581-020-00381-4.

Sinha S, Swami R, Shakir A, Salman Ali S, Bansode J, Mehta K. Clinical Profile and Outcome of Hemodialysis Patients with SARS COV2 Infection in a Tertiary Care Centre in Mumbai, India. Indian J Nephrol. 2021;31(5):442-448. doi:10.4103/ijn.IJN_377_20.

Chen CY, Shao SC, Chen YT, Hsu CK, Hsu HJ, Lee CC, et al. Incidence and Clinical Impacts of COVID-19 Infection in Patients with Hemodialysis: Systematic Review and Meta-Analysis of 396,062 Hemodialysis Patients. Healthcare (Basel). 2021;9(1):47. doi: 10.3390/healthcare9010047.

Xiong F, Tang H, Liu L, Tu C, Tian JB, Lei CT, et al. Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, China. J Am Soc Nephrol. 2020;31(7):1387-1397. doi: 10.1681/ASN.2020030354.

Kikuchi K, Nangaku M, Ryuzaki M, Yamakawa T, Yoshihiro O, Hanafusa N, et al. Survival and predictive factors in dialysis patients with COVID-19 in Japan: a nationwide cohort study. Ren Replace Ther. 2021;7(1):59. doi: 10.1186/s41100-021-00378-0.

Clark A, Jit M, Warren-Gash C, Guthrie B, Wang HHX, Mercer SW, Sanderson C, et al; Centre for the Mathematical Modelling of Infectious Diseases COVID-19 working group. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. Lancet Glob Health. 2020;8(8):e1003-e1017. doi: 10.1016/S2214-109X(20)30264-3.

ERA-EDTA Council; ERACODA Working Group. Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA. Nephrol Dial Transplant. 2021;36(1):87-94. doi: 10.1093/ndt/gfaa314.

Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430-436. doi: 10.1038/s41586-020-2521-4.

Turgutalp K, Ozturk S, Arici M, Eren N, Gorgulu N, Islam M, et al. Determinants of mortality in a large group of hemodialysis patients hospitalized for COVID-19. BMC Nephrol. 2021;22(1):29. doi: 10.1186/s12882-021-02233-0.

Smolander J, Bruchfeld A. The COVID-19 Epidemic: Management and Outcomes of Hemodialysis and Peritoneal Dialysis Patients in Stockholm, Sweden. Kidney Blood Press Res. 2021;46(2):250-256. doi: 10.1159/000514268.

Carriazo S, Mas-Fontao S, Seghers C, Cano J, Goma E, Avello A, et al. Increased 1-year mortality in haemodialysis patients with COVID-19: a prospective, observational study, Clinical Kidney Journal, 2021;sfab248, doi: 10.1093/ckj/sfab248

Chawki S, Buchard A, Sakhi H, Dardim K, El Sakhawi K, Chawki M, et al; HD-CovIDF Study Group. Treatment impact on COVID-19 evolution in hemodialysis patients. Kidney Int. 2020 Oct;98(4):1053-1054. doi: 10.1016/j.kint.2020.07.010.

National Kidney Foundation. KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update. Am J Kidney Dis. 2015;66(5):884-930. doi: 10.1053/j.ajkd.2015.07.015.

Wu MY, Hsu YH, Bai CH, Lin YF, Wu CH, Tam KW. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials. Am J Kidney Dis. 2012;59(6):810-8. doi: 10.1053/j.ajkd.2011.11.030.

Adapa S, Aeddula NR, Konala VM, Chenna A, Naramala S, Madhira BR. COVID-19 and renal failure: challenges in the delivery of renal replacement therapy. J. Clin. Med. Res. 2020;12(5):276–285. doi: 10.14740/jocmr4160.

Link A, Girndt M, Selejan S, Mathes A, Böhm M, Rensing H. Argatroban for anticoagulation in continuous renal replacement therapy. Crit Care Med. 2009;37(1):105-10. doi: 10.1097/CCM.0b013e3181932394.

Chaijamorn W, Rungkitwattanakul D, Nuchtavorn N, Charoensareerat T, Pattharachayakul S, Sirikun W, et al. Antiviral Dosing Modification for Coronavirus Disease 2019-Infected Patients Receiving Extracorporeal Therapy. Crit Care Explor. 2020;2(10):e0242. doi: 10.1097/CCE.0000000000000242.

Moradian ST, Parandeh A, Khalili R, Karimi L. Delayed Symptoms in Patients Recovered from COVID-19. Iran J Public Health. 2020 Nov;49(11):2120-2127. doi: 10.18502/ijph.v49i11.4729.

Mahalingasivam V, Craik A, Tomlinson LA, Ge L, Hou L, Wang Q, et al. A Systematic Review of COVID-19 and Kidney Transplantation. Kidney Int Rep. 2021;6(1):24-45. doi: 10.1016/j.ekir.2020.10.023.

Ribeiro HS, Rodrigues AE, Cantuária J, Inda-Filho A, Bennett PN. Post-COVID-19 rehabilitation: a special look at chronic kidney disease patients. Ren Replace Ther. 2021;7(1):33. doi: 10.1186/s41100-021-00355-7.

Daynes E, Gerlis C, Chaplin E, Gardiner N, Singh SJ. Early experiences of rehabilitation for individuals post-COVID to improve fatigue, breathlessness exercise capacity and cognition - A cohort study. Chron Respir Dis. 2021;18:14799731211015691. doi: 10.1177/14799731211015691.

Moro T, Paoli A. When COVID-19 affects muscle: effects of quarantine in older adults. Eur J Transl Myol. 2020 Jun 17;30(2):9069. doi: 10.4081/ejtm.2019.9069.

Smart NA, Williams AD, Levinger I, Selig S, Howden E, Coombes JS, et al. Exercise & Sports Science Australia (ESSA) position statement on exercise and chronic kidney disease. J Sci Med Sport. 2013;16(5):406-11. doi: 10.1016/j.jsams.2013.01.005.

Painter P, Messer-Rehak D, Hanson P, Zimmerman SW, Glass NR. Exercise capacity in hemodialysis, CAPD, and renal transplant patients. Nephron. 1986;42(1):47-51. doi: 10.1159/000183632.

Ng JH, Hirsch JS, Wanchoo R, Sachdeva M, Sakhiya V, Hong S, et al; Northwell COVID-19 Research Consortium and the Northwell Nephrology COVID-19 Research Consortium. Outcomes of patients with end-stage kidney disease hospitalized with COVID-19. Kidney Int. 2020;98(6):1530-1539. doi: 10.1016/j.kint.2020.07.030.

Zhou H, Lu S, Chen J, Wei N, Wang D, Lyu H, et al. The landscape of cognitive function in recovered COVID-19 patients. J Psychiatr Res. 2020;129:98-102. doi: 10.1016/j.jpsychires.2020.06.022.

Liu K, Zhang W, Yang Y, Zhang J, Li Y, Chen Y. Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study. Complement Ther Clin Pract. 2020;39:101166. doi: 10.1016/j.ctcp.2020.101166.

Kuodi P, Gorelik Y, Zayyad H, Wertheim O, Wiegler KB, Jabal KA, et al. Association between vaccination status and reported incidence of post-acute COVID-19 symptoms in Israel: a cross-sectional study of patients tested between March 2020 and November 2021; preprint: medRxiv 2022.01.05.22268800; doi: 10.1101/2022.01.05.22268800.

Office for National Statistics. Self-reported long COVID after two doses of a coronavirus (COVID-19) vaccine in the UK: 26 January 2022. [Internet]. Available at : https://www.ons.gov.uk/releases/selfreportedlongcovidafterdoublecoronaviruscovid19vaccination.

>

Постковідний синдром у хворих на хронічну хворобу нирок VД та реципієнтів ниркового трансплантату

Анотація

Завантаження

Посилання